Christopher D. Byrne
Impact in
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diet, Metabolism, and Disease
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
- Epidemiology 256
- Liver Disease Diagnosis and Treatment 243
-
- Diet, Metabolism, and Disease 86
- Diabetes, Cardiovascular Risks, and Lipoproteins 38
- Co-authors
- Giovanni Targher (179 shared papers)Alessandro Mantovani (55 shared papers)Herbert Tilg (21 shared papers)Eleonora Scorletti (36 shared papers)Sarah H. Wild (73 shared papers)Amedeo Lonardo (13 shared papers)Giacomo Zoppini (17 shared papers)Ming‐Hua Zheng (87 shared papers)
- Journals
- Liver International (25 papers)Diabetic Medicine (18 papers)Metabolism (16 papers)Diabetes Obesity and Metabolism (15 papers)Gut (14 papers)
- Partner nations
- United KingdomItalyChina
In The Last Decade
Christopher D. Byrne
496 papers receiving 27.9k citations
Christopher D. Byrne's Hit Papers
Peers
Comparison fields: 5 of 182
- Epidemiology 15.0k
- Endocrinology, Diabetes and Metabolism 7.3k
- Hepatology 2.9k
- Physiology 3.6k
- Pathology and Forensic Medicine 2.1k
Countries citing papers authored by Christopher D. Byrne
This map shows the geographic impact of Christopher D. Byrne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher D. Byrne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher D. Byrne more than expected).
Fields of papers citing papers by Christopher D. Byrne
This network shows the impact of papers produced by Christopher D. Byrne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher D. Byrne. The network helps show where Christopher D. Byrne may publish in the future.
Co-authors
The 25 scholars most cited alongside Christopher D. Byrne, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 511 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | NAFLD: A multisystem disease Hit paper breakdown → | 2015 | 2323 |
| 2 | Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis Hit paper breakdown → | 2016 | 1040 |
| 3 | The complex link between NAFLD and type 2 diabetes mellitus — mechanisms and treatments Hit paper breakdown → | 2021 | 583 |
| 4 | NAFLD and increased risk of cardiovascular disease: clinical associations, pathophysiological mechanisms and pharmacological implications Hit paper breakdown → | 2020 | 575 |
| 5 | Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis Hit paper breakdown → | 2018 | 467 |
| 6 | 1996 | 435 | |
| 7 | MASLD: a systemic metabolic disorder with cardiovascular and malignant complications Hit paper breakdown → | 2024 | 430 |
| 8 | Complications, morbidity and mortality of nonalcoholic fatty liver disease Hit paper breakdown → | 2020 | 422 |
| 9 | Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis Hit paper breakdown → | 2021 | 415 |
| 10 | Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Hit paper breakdown → | 2012 | 373 |
| 11 | 2009 | 371 | |
| 12 | Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach Hit paper breakdown → | 2021 | 370 |
| 13 | Current status and future trends of the global burden of MASLD Hit paper breakdown → | 2024 | 366 |
| 14 | Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups Hit paper breakdown → | 2015 | 362 |
| 15 | Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals Hit paper breakdown → | 2020 | 340 |
| 16 | NAFLD as a driver of chronic kidney disease Hit paper breakdown → | 2020 | 334 |
| 17 | Nonalcoholic fatty liver disease and chronic vascular complications of diabetes mellitus Hit paper breakdown → | 2017 | 304 |
| 18 | 2020 | 299 | |
| 19 | 1998 | 286 | |
| 20 | Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis Hit paper breakdown → | 2020 | 276 |
About Christopher D. Byrne
Christopher D. Byrne is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism, Molecular Biology, Physiology and Surgery, having authored 511 papers that have together received 28.6k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (243 papers), Diet, Metabolism, and Disease (86 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Liver Disease and Transplantation (28 papers), Alcohol Consumption and Health Effects (25 papers), Diet and metabolism studies (24 papers), Metabolism, Diabetes, and Cancer (20 papers) and Lipoproteins and Cardiovascular Health (18 papers). The work is most often cited by research in Epidemiology (15.0k citations), Endocrinology, Diabetes and Metabolism (7.3k citations), Hepatology (2.9k citations), Physiology (3.6k citations) and Pathology and Forensic Medicine (2.1k citations). Christopher D. Byrne has collaborated with scholars based in United Kingdom, Italy and China. Frequent co-authors include Giovanni Targher, Alessandro Mantovani, Herbert Tilg, Eleonora Scorletti, Sarah H. Wild, Amedeo Lonardo, Giacomo Zoppini, Ming‐Hua Zheng, Kathleen E. Corey and Ki‐Chul Sung. Their work appears in journals such as Liver International, Diabetic Medicine, Metabolism, Diabetes Obesity and Metabolism and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.